Hemato Oncology Testing Market Report 2025-2030: Minimally Invasive Diagnostics Propel Hemato Oncology Testing Market Growth, Expected to Reach $10.71 Billion by 2030
December 13, 2024 09:39 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Market by Products & Services, Cancer, Technology, End-User - Global Forecast 2025-2030" report has been added to ...
Enterome’s Immunotherapy EO2463 Shows Early Clinical Response in Newly Diagnosed Follicular Lymphoma Suggesting a Potential Alternative to 'Watchful Waiting'
December 10, 2024 11:43 ET
|
Enterome
46% objective response rate, with 15% complete responses and 31% partial responses in patients with early-stage follicular lymphoma reported at the ASH 2024 meeting.Well-tolerated treatment with no...
Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target PD-1 and PD-L1 Pathways have Set New Benchmarks
December 05, 2024 10:16 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Immuno-Oncology...
Enterome to Present New Clinical Data and Biomarker Findings for EO2463 at the 2024 American Society of Hematology (ASH) Annual Meeting
November 06, 2024 06:00 ET
|
Enterome
Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monotherapy in a...
Hemato-Oncology Testing Market to Cross $12.7 Billion by 2034: Industry Trends and Analysis Featuring Profiles of Leading Market Players, Including EntroGen, Cepheid, Bio-Rad Labs, ArcherDX, Qiagen
June 05, 2024 04:20 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Hemato-Oncology Testing Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Hemato Oncology Testing Market Anticipated to Surge Amid Technological Innovations and Increased Cancer Prevalence
January 22, 2024 21:23 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest comprehensive research on...
AI in Oncology for Analytical Solutions Market - Global Forecast to 2033: Market to Grow at a CAGR of 35.11%
April 03, 2023 10:18 ET
|
Research and Markets
Dublin, April 03, 2023 (GLOBE NEWSWIRE) -- The "AI in Oncology for Analytical Solutions Market by Cancer Type, by Component, and by Region - Global Forecast to 2023-2033" report has been added to ...
Global Hemato Oncology Testing Market Report 2022 to 2027: Drug Diagnostics Co-Development Presents Opportunities
December 12, 2022 08:14 ET
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma...
Oncology Precision Medicine Market Report 2022: Featuring Novartis, F. Hoffmann-La Roche, Merck & Co, Quest Diagnostics & More
November 23, 2022 08:08 ET
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem, By Application and By...